Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT00840931 · COMPLETED
Trial details
- NCT number
- NCT00840931
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-02
- Primary completion
- 2014-02-17
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.